Andrew Hykes - Apr 1, 2024 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Apr 1, 2024
Transactions value $
$0
Form type
4
Date filed
4/3/2024, 04:43 PM
Previous filing
Feb 21, 2024
Next filing
May 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Tax liability $0 -508 -0.11% $0.00 472K Apr 1, 2024 Direct F1
transaction NARI Common Stock Tax liability $0 -947 -0.2% $0.00 471K Apr 1, 2024 Direct F2
transaction NARI Common Stock Tax liability $0 -1.48K -0.31% $0.00 470K Apr 1, 2024 Direct F3
transaction NARI Common Stock Tax liability $0 -1.29K -0.28% $0.00 468K Apr 1, 2024 Direct F4
holding NARI Common Stock 1.55K Apr 1, 2024 By Child 1
holding NARI Common Stock 1.55K Apr 1, 2024 By Child 2
holding NARI Common Stock 1.55K Apr 1, 2024 By Child 3
holding NARI Common Stock 1K Apr 1, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
F2 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
F3 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
F4 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.